Treatment of recurrent and persistent Cushing's disease after first transsphenoidal surgery: lessons learned from an international meta-analysis.
Carlos Perez-VegaAndres Ramos-FresnedoShashwat TripathiRicardo A DomingoKrishnan RavindranJoao P AlmeidaJennifer PetersonDaniel M TrifilettiKaisorn L ChaichanaAlfredo Quinones-HinojosaSusan L SamsonPublished in: Pituitary (2022)
Both TSS and SRS are possible approaches for the treatment of recurrent or persistent CD after a first TSS. Our data show that either TSS or SRS represent viable treatment options to achieve remission for this subset of patients.